Pharmacological fibrinolysis
Chakrabarti, R.; Fearnley, G.R.
Acta Universitatis Carolinae. Medica. Monographia 52: 15-17
1972
ISSN/ISBN: 0567-8250 PMID: 4361262 Document Number: 49844
Document emailed within 1 workday
Related Documents
Guerrini, M.; Pieragalli, D.; Acciavatti, A.; Galigani, C.; Guideri, F.; Franchi, M.; Landini, F.; Burresi, A.; Messa, G.L.; Frigerio, C. 1989: Calcium dobesilate, hemorheology, fibrinolysis and endothelium. New perspectives on the prevention of diabetic microangiopathy. Clinical pharmacological study La Clinica Terapeutica 129(4): 271-285Jovan P. Antovic 2003: Thrombin Activatable Fibrinolysis Inhibitor (TAFI) A Link between Coagulationand Fibrinolysis Clinical Laboratory 49(9-10): 475-486
Munkvad, S. 1993: Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways Danish Medical Bulletin 40(4): 383-408
Liao, J.F.; Chen, C.F.; Chow, S.Y. 1981: Pharmacological studies of Chinese herbs. (9) Pharmacological effects of Evodiae fructus Journal of the Formosan Medical Association 80(1): 30-38
Chow, S.Y.; Chen, C.F.; Chen, S.M. 1977: Pharmacological studies of Chinese herbs. (6) Pharmacological effects of Epiphyllum oxypetalum Haw Journal of the Formosan Medical Association 76(12): 916-925
Johnson, G.F.; Wilson, P. 1989: The management of depression: a review of pharmacological and non-pharmacological treatments Medical Journal of Australia 151(7): 397-400 403 406
Haulică, I.; Bild, W.; Boişteanu, D. 2006: Biosynthesis and physio-pharmacological actions of angiotensin peptides: 2. Physio-pharmacological properties Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 110(2): 384-390
Hojo, M.; Nagasaka, Y.; Katayama, O.; Serizawa, I. 1981: Pharmacological study of Mequitazine (LM-209). (V). Pharmacological actions of a main metabolite of LM-209, mequitazine sulfoxide (LM-209 SO) Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 78(5): 431-438
Konno, F.; Kobayashi, C.; Morimoto, R.; Takayanagi, I.; Cho, N.; Hirobe, M. 1986: Pharmacological effects of nalorphine and nalorphine-7,8-oxide (nalorphine-epoxide): interaction of the intrinsic activity, affinity and pharmacological responses Archives Internationales de Pharmacodynamie et de Therapie 282(2): 219-232
Dilov, P.; Antonov, S.; Chakŭrov, R.; Petkov, R.; Gabrovski, P. 1984: Dextrofer-100 with B12 and dextrofer-100--comparative pharmacological and clinico-pharmacological studies Veterinarno-Meditsinski Nauki 21(6): 91-100
Dzhurdzhev, A.; Atanasov, K. 1981: Nonenzymatic fibrinolysis Vutreshni Bolesti 20(3): 18-22
Clavé, M. 1974: Physiology of fibrinolysis Revue de l'Infirmiere 24(8): 781-782
Cederholm-Williams, S.A. 1983: Control of fibrinolysis British Journal of Hospital Medicine 30(2): 107-110
Bergut, F.A. 1973: Evaluation of the effectiveness of fibrinolysis Laboratornoe Delo 11: 698-699
Sobel, B.E. 1987: Fibrinolysis and activators of plasminogen Heart and Lung: the Journal of Critical Care 16(6 Part 2): 775-779
Kaneko, Y. 1983: Significance of fibrinolysis in ovulation Nihon Sanka Fujinka Gakkai Zasshi 35(2): 117-126
Syrbe, G.; Jütte, A.; Wittwer, E.; Deufrains, A. 1986: Fibrinolysis in diabetes mellitus Folia Haematologica 113(3): 317-328
Kuznik, B.I.; Savushkin, A.V.; Shasaitova, M.S. 1977: Assessment of fibrinolysis with a coagulograph H-333 Laboratornoe Delo 5: 281-283
Skiftis, T. 1971: Therapeutic fibrinolysis during pregnancy Geburtshilfe und Frauenheilkunde 31(6): 568-571
Belleville, J. 1972: Physiology of coagulation and fibrinolysis Lyon Medical 19(Suppl): 103-112